INVESTIGATING THE EFFICACY AND SAFETY OF SGLT2 INHIBITORS FOR CARDIOVASCULAR PROTECTION IN PATIENTS WITH OBESITY AND TYPE 2 DIABETES. The Research of Medical Science Review, [S. l.], v. 3, n. 4, p. 307–312, 2025. Disponível em: http://www.thermsr.com/index.php/Journal/article/view/929.. Acesso em: 30 apr. 2025.